Your Partner. For science. For life.

Battling chronic ailments. Evolving science. Improving quality of life. Even helping people get a better night’s sleep. Our portfolio companies are positively impacting the world every day with their visionary people and life-changing products.

What they do.

Quantapore Inc. is focused on the development and commercialization of an ultra low-cost, high-throughput DNA sequencing platform. Based in Menlo Park, CA, the company was founded in 2009 and is well on its way to the commercialization of its novel sequencing platform.

Status:

Quantapore is in development of its revolutionary sequencing platform that will combine low cost, long reads, simple workflow and fast sample-to-result turnaround time. Because of this, it holds the promise to be one of the world’s leading sequencing system providers.

Achievement of Note:

Quantapore recently closed a Series C financing round led by China BioPharma Capital I, a venture capital fund advised by TVM Capital Life Science via its Hong Kong based office.

How they‘re improving the quality of peoples lives:

Quantapore is seeking to be a catalyst in the personalized medicine revolution by providing physicians with a low-cost method of sequencing genes rapidly in order to match therapies that can help save lives.